Q. What company makes Exjade?
Exjade (deferasirox) is an oral iron chelator developed and manufactured by Novartis. Image courtesy of Novartis AG. Exjade is available for oral administration in 125mg, 250mg and 500mg doses. Image courtesy of Novartis AG.
Q. How do you make Exjade?
Exjade is taken once a day at around the same time. The dispersible tablets should be taken on an empty stomach (at least 30 minutes before food), and the film-coated tablets and granules can be taken on an empty stomach or with a light meal.
Q. Who prescribes deferasirox?
Exjade (deferasirox) is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older. The recommended initial daily dose of Exjade is 20 mg/kg body weight.
Q. When did exjade go generic?
January 26th, 2016
A generic version of EXJADE was approved as deferasirox by ACTAVIS ELIZABETH on January 26th, 2016.
Q. When did Exjade go generic?
Q. What is deferasirox used for?
This medication is used to treat ongoing high levels of iron in the body caused by multiple blood transfusions. It is also used to treat high levels of iron in people with a certain blood disorder who do not require blood transfusions (non-transfusion-dependent thalassemia).
Q. What are the side effects of deferasirox?
COMMON side effects
- throat irritation.
- nausea.
- vomiting.
- diarrhea.
- elevation of proteins in the urine.
- intense abdominal pain.
Q. How do you take Desirox?
Desirox 500 Tablet should be taken on an empty stomach. Take it in the exact dose and duration and take it regularly at a fixed time each day to get the maximum benefit from it. Using of Desirox 500 Tablet may cause common side effects such as nausea, headache, constipation, diarrhea, and increased liver enzyme.
Q. What is the difference between Exjade and Jadenu?
Jadenu is a new oral formulation of Exjade tablets for oral suspension. While Exjade is a dispersible tablet that must be mixed in liquid and taken on an empty stomach, Jadenu can be taken in a single step, with or without a light meal, simplifying administration of treatment for chronic iron overload.
Q. How many countries are approved for Exjade tablets?
This is an international site for EXJADE ® (deferasirox) and is intended for healthcare professionals outside the United States. EXJADE is approved for use in more than 100 countries around the world.
Q. Are there any side effects to the drug Exjade?
Exjade can cause hepatic injury, fatal in some patients. In Study 1, 4 patients (1.3%) discontinued Exjade because of hepatic toxicity (drug-induced hepatitis in 2 patients and increased serum transaminases in 2 additional patients). Hepatic toxicity appears to be more common in patients greater than 55 years of age.
Q. How is Exjade used in the European Union?
This medicine is authorised for use in the European Union. Exjade is a medicine used to treat chronic iron overload (an excess of iron in the body) in:
Q. How is Exjade used to treat iron overload?
Exjade is a medicine used to treat chronic iron overload (an excess of iron in the body) in: patients from 6 years of age who have beta thalassaemia major (an inherited blood disorder in which patients do not have enough normal haemoglobin in the blood) and who receive frequent blood transfusions;
https://www.youtube.com/watch?v=1zmy0afxn7w
